Bruker Corporation to Present at Cowen’s 42nd Annual Health Care Conference

Rhea-AI Summary

Bruker Corporation (Nasdaq: BRKR) will participate in Cowen’s 42nd Annual Health Care Conference from March 7-9, 2022. Gerald Herman, Executive VP & CFO, will present on March 7, 2022, at 2:50 PM EST. A live webcast of the presentation will be accessible on the Company’s Investor Relations website, with a replay available for 90 days post-event. Bruker specializes in high-performance scientific instruments and solutions that enhance life sciences and diagnostics, empowering scientific breakthroughs.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today it will participate in Cowen’s 42nd Annual Health Care Conference which is taking place virtually on March 7 - 9, 2022. Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, March 7^th, 2022 at 2:50 PM Eastern Standard Time.

A live audiovisual webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 90 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005294/en/

Justin Ward

Sr. Director, Investor Relations & Corporate Development

Bruker Corporation

T: +1 (978) 663–3660, ext. 1479

E: Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

When is Bruker Corporation participating in the Cowen Health Care Conference?

Bruker Corporation will participate in the Cowen’s 42nd Annual Health Care Conference from March 7-9, 2022.

Who will present for Bruker Corporation at the conference?

Gerald Herman, Executive Vice President & CFO, will present for Bruker Corporation.

What time is Bruker Corporation's presentation on March 7, 2022?

Bruker Corporation's presentation is scheduled for 2:50 PM Eastern Standard Time on March 7, 2022.

Where can I watch the Bruker Corporation presentation?

The presentation can be watched live on the Investor Relations section of Bruker Corporation's website.

Will there be a replay of Bruker Corporation's conference presentation?

Yes, a replay of the presentation will be available for 90 days after the event on their Investor Relations website.